Dr. Noll Campbell, Dr. Babar Khan, and Dr. Sikandar Khan man “mission control” during the meeting.
The COVID-19 pandemic has posed many challenges for conference organizers around the world. Two Regenstrief Institute research scientists successfully adjusted the American Delirium Society (ADS) conference from in-person to virtual and attracted more than 400 registrations from around the world.
The digital meeting was co-chaired by Indiana University Center for Aging Research at Regenstrief Institute Associate Director Babar Khan, M.D., M.S., and Regenstrief research scientist Noll Campbell, PharmD, M.S. Dr. Khan was the 2019-2020 president of the ADS, and Dr. Campbell is the ADS treasurer.
Regenstrief research scientist Sikandar Khan, D.O., and Indiana University School of Medicine administrative coordinator Makenna Flory assisted with managing the technology during the presentations.
The digital meeting featured about three dozen experts discussing the latest delirium-related research. The ADS works to lead the effort to foster research, education, quality improvement, advocacy and implementation science to minimize the impact of delirium on the health and wellbeing of patients.
Regenstrief researchers are pioneers in the field of delirium and have played an important role in the diagnosis and treatment of ADS. Regenstrief scientist Malaz Boustani, M.D., MPH, was the founding president of the organization.
The next meeting will take place in Indianapolis in March 2021.
